7 unknown. 7 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Unknown 7 |
| Phase 2 | 2 | Unknown 2 |
Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ADRCs in The Treatment of Hand Dysfunction Due to Scleroderma ADRCs, Standard Care, Placebo - Scleroderma, Diffuse | Phase 3 | Unknown | Paracrine, INC. | 174 | 2023-02-28 | 2022-09-28 |
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease | Phase 2 / Phase 3 | Unknown | Paul R Fortin | 287 | 2022-03-09 | 2023-01-17 |
| Effects of Probiotics on Gastrointestinal Symptoms and on the Immune System in Patients With Systemic Sclerosis Probiotic, Placebo - Systemic Sclerosis, Scleroderma | Phase 3 | Unknown | Federal University of São Paulo | 76 | 2014-12-01 | 2014-11-27 |
| Serial Night Time Position Splint on Systemic Sclerosis Serial night time position splint, Drug treatment - Diffuse Systemic Sclerosis | Phase 3 | Unknown | Federal University of São Paulo | 76 | 2010-01-01 | 2012-05-01 |
| Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms 0.9% nitroglycerin in TAM cream, vehicle cream - Raynaud Disease | Phase 3 | Unknown | MediQuest Therapeutics | 100 | 2009-06-01 | 2010-07-20 |
| A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon Nitroglycerin, Topical AmphiMatrix - Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma | Phase 3 | Unknown | MediQuest Therapeutics | 200 | 2007-12-01 | 2010-02-05 |
| High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis N-acetylcysteine (NAC) - Scleroderma, Diffuse | Phase 2 / Phase 3 | Unknown | Università Politecnica delle Marche | 45 | 2007-01-01 | 2007-01-30 |
Scleroderma, Systemic (3) · Raynaud Disease (2) · Arthritis, Rheumatoid (1) · Lupus Erythematosus, Systemic (1) · MASS syndrome (1) · Systemic Vasculitis (1) · Undifferentiated Connective Tissue Diseases (1)
Connective Tissue Diseases (7) · Skin Diseases (7) · Skin and Connective Tissue Diseases (7) · Scleroderma, Systemic (4) · Cardiovascular Diseases (3) · Vascular Diseases (3) · Embolism and Thrombosis (2) · Livedoid Vasculopathy (2) · Peripheral Vascular Diseases (2) · Skin Diseases, Vascular (2) · Thrombosis (2) · Arthritis (1) · Autoimmune Diseases (1) · Immune System Diseases (1) · Joint Diseases (1)
Nitroglycerin (2) · Acetylcysteine (1) · COVID-19 Vaccines (1) · Probiotics (1) · Standard of Care (1)
Federal University of São Paulo (2) · MediQuest Therapeutics (2) · Paracrine, INC. (1) · Paul R Fortin (1) · Università Politecnica delle Marche (1)
Brazil (2) · United States (2) · Canada (1) · Italy (1)
Armando Gabrielli, MD,professor (1) · Cristiane Kayser (1) · Jamil Natour, PhD (1) · Jan Ohrstrom, PhD (1) · Jeff Gregory, MD (1) · Paul R Fortin, MD,MPH,FRCPC (1)